Good morning :)
$
₹
Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

TMO

NYSE
Asset Logo

Thermo Fisher Scientific Inc

TMO

NYSE
$684.811.63% (+10.99)
$
₹
$684.811.63% (+10.99)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Diagnostics & Research

Mega Cap

With a market cap of $249.1B the stock is ranked 58

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

35.53
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

4.62
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$18.96
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.96
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

14.94%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.06%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 27 analysts reports

Buy
23 analysts
Hold
3 analysts
Sell
1 analyst

Price Upside

+11.44%

Earnings Growth

+10.45%

Rev. Growth

+7.7%

See Detailed Forecast

Company Profile

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Agilent Technologies Inc
A
Agilent Technologies Inc
P/E Ratio
34.13
34.13
1Y Return
17.92%
17.92%
Buy Reco %
66.66
66.66
IQVIA Holdings Inc
IQV
IQVIA Holdings Inc
P/E Ratio
34.70
34.70
1Y Return
27.03%
27.03%
Buy Reco %
90.47
90.47
Waters Corporation
WAT
Waters Corporation
P/E Ratio
114.85
114.85
1Y Return
27.55%
27.55%
Buy Reco %
78.26
78.26
Illumina Inc
ILMN
Illumina Inc
P/E Ratio
50.26
50.26
1Y Return
169.5%
169.5%
Buy Reco %
52.38
52.38
Mettler-Toledo International Inc
MTD
Mettler-Toledo International Inc
P/E Ratio
37.64
37.64
1Y Return
16.17%
16.17%
Buy Reco %
38.46
38.46
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Lower price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 11.44% growth, versus a trailing 3-year CAGR of 13.65%.

2026
Current$673.82Baseline
Analyst Target - 1 year
Target$750.92+11.44%

All values in $

202220232024202520262027$556.69$646.46$736.24Target+11.44%
2026
Current$673.82Baseline
Analyst Target - 1 year
Target$750.92+11.44%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 7.70% growth, versus a trailing 3-year CAGR of -0.27%.

2025
Current$44.55Baseline
Forecast for Dec 2026
High$48.22+8.23%
Average$47.98+7.7%
Low$47.72+7.12%

All values in $ Billion

20212022202320242025202639.2144.9142.8542.8744.55Low+7.12%Average+7.7%High+8.23%
2025
Current$44.55Baseline
Forecast for Dec 2026
High$48.22+8.23%
Average$47.98+7.7%
Low$47.72+7.12%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 10.45% growth, versus a trailing 3-year CAGR of -0.53%.

2025
Current$22.87Baseline
Forecast for Dec 2026
High$25.4+11.06%
Average$25.26+10.45%
Low$25.03+9.44%

All values in $

20212022202320242025202625.1123.2421.5421.8622.87Low+9.44%Average+10.45%High+11.06%
2025
Current$22.87Baseline
Forecast for Dec 2026
High$25.4+11.06%
Average$25.26+10.45%
Low$25.03+9.44%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

12.2
1.9
11
1.6
11.9
1.7
12.1
1.7
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue10.5410.5911.3910.3610.8511.1212.211111.9912.13
Net Income1.541.631.831.501.611.611.971.651.731.72
Net Profit Margin14.68%15.38%16.05%14.54%14.89%14.52%16.16%15.00%14.47%14.17%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDiagnostics & Research

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Thermo Fisher Scientific Inc 35.534.621.96
Agilent Technologies Inc34.135.881.26
IQVIA Holdings Inc34.707.170.97
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare TMO with any stock or ETF
Compare TMO with any stock or ETF
Comparing from
TMO
A
IQV
Loading...

Frequently asked questions

  1. Thermo Fisher Scientific Inc (TMO) share price today is $684.81 as of October 27, 2026 at 1:29 AM IST. The stock touched a day high of $685.21 and a day low of $676.14.

  2. Thermo Fisher Scientific Inc stock trades on NYSE under the ticker symbol TMO.

  3. Thermo Fisher Scientific Inc's market capitalization is $249.14B as of October 27, 2026 at 1:29 AM IST.

  4. Thermo Fisher Scientific Inc's price-to-earnings (P/E) ratio is 35.53 as of October 26, 2026.

  5. Thermo Fisher Scientific Inc's price-to-book (P/B) ratio is 4.62 as of October 26, 2026.

  6. Yes, Thermo Fisher Scientific Inc pays a dividend, with a current dividend yield of 0.06%.

  7. Yes, You can buy Thermo Fisher Scientific Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Thermo Fisher Scientific Inc shares in three steps: 1. Search Thermo Fisher Scientific Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Thermo Fisher Scientific Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Thermo Fisher Scientific Inc (TMO) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0146 shares at the current price of $684.81.

Loading...